Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MSH2 |
Variant | K550T |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | MSH2 K550T lies within the clamp domain of the Msh2 protein (PMID: 17531815). K550T has been identified in sequencing studies (PMID: 22810696), but has not been biochemically characterized and therefore, its effect on Msh2 protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
MSH2 mutant MSH2 K550T |
Transcript | NM_000251.3 |
gDNA | chr2:g.47466796A>C |
cDNA | c.1649A>C |
Protein | p.K550T |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406638.1 | chr2:g.47466757A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_000251 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406637.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406646.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406640.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406631.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_000251.2 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
XM_005264332.4 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406648.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406635.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406674.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
XM_047444416.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406645.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
XM_011532867 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
XM_011532867.2 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406641.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406632.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406642.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406644.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406657.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406639.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406655.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406643.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406633.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
XM_005264332 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_000251.3 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
NM_001406634.1 | chr2:g.47466796A>C | c.1649A>C | p.K550T | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
MSH2 mutant | small intestine adenocarcinoma | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing small bowel adenocarcinoma (NCCN.org). | detail... |
MSH2 mutant | rectum cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colorectal cancer (NCCN.org). | detail... |
MSH2 mutant | endometrial carcinoma | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH2 result in Lynch syndrome, which is associated with increased risk of developing endometrial carcinoma (NCCN.org). | detail... |
MSH2 mutant | colon cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colon cancer (NCCN.org). | detail... |
MSH2 mutant | ovarian cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH2 result in Lynch syndrome, which is associated with increased risk of ovarian cancer (NCCN.org). | detail... |
MSH2 mutant | stomach cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH2 result in Lynch syndrome, which is associated with increased risk of early onset of gastric cancer (NCCN.org). | detail... |
MSH2 mutant | pancreatic cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH2 result in Lynch syndrome, which is associated with increased risk of developing pancreatic cancer (NCCN.org). | detail... |